Subscribe
china-istock-490309714-kagenmi
Kagenmi / iStockphoto.com
29 June 2021Big PharmaAlex Baldwin

What China’s new patent laws mean for life sciences

On June 1, 2021, the Chinese government implemented crucial changes to its patent laws, hoping to create better protections for national and international inventors.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
Beckman Coulter loses late-stage bid to pause infringement proceedings
17 May 2022   The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Medtech
Beckman Coulter loses late-stage bid to pause infringement proceedings
17 May 2022   The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.

More on this story

Medtech
Beckman Coulter loses late-stage bid to pause infringement proceedings
17 May 2022   The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.

More features

Judge denies Intellia bid to throw out suit over $100m Regeneron pact
‘AI curious’ counsel at AZ, Novartis weigh risks and benefits
Trump’s return sparks calls for pro-patent agenda
EOFlow ordered to pay rival $452m over insulin patch trade secrets
Amgen faces pushback over bid to narrow patent scope
LSPN Europe: Navigating the EPO and lessons from the UPC frontline
Paul Hastings reinforces London office with high-tech patent litigator
Gene tech firm fends off injunction in test kit dispute